PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Mar-2025 Ryvu Therapeutics to Present Preclinical Data on Synthetic Lethality at the 2025 AACR Annual Meeting Ryvu Therapeutics
27-Mar-2025 How pre-assembled packaging relieves the burden on pharmaceutical manufacturers Faller Packaging
27-Mar-2025 Clinical trials company Panthera preparing to take part in Race for Life Manchester 10k 2025 Panthera Biopartners
27-Mar-2025 Chiesi Acquires New Manufacturing Site in Nerviano (Milan) with a Strategic €430 Million Investment To 2030 to Drive Global Growth Chiesi
27-Mar-2025 Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata Alys Pharmaceuticals
27-Mar-2025 Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director Kelso Pharma
27-Mar-2025 Santhera proposes Dr. Melanie Rolli as new member of Board of Directors Santhera Pharmaceuticals
27-Mar-2025 European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Merck
27-Mar-2025 Evolva Holding SA shareholders elect Clearway representatives to the Board of Directors Evolva Holding SA
27-Mar-2025 RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned RHÖN-KLINIKUM Aktiengesellschaft
27-Mar-2025 Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal GmbH
27-Mar-2025 Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE
27-Mar-2025 Marinomed focuses on growth after successful restructuring Marinomed Biotech AG
27-Mar-2025 Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe beim Lead-Projekt C-PTBE-01 Curatis Holding AG
27-Mar-2025 Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position Formycon AG
26-Mar-2025  Abivax publishes financial reports with the French and U.S. securities regulatory agencies ABIVAX
26-Mar-2025 Over half of UK patients surveyed with hypoparathyroidism dissatisfied with treatment, finds largest ever UK survey of the UK hypoparathyroidism community Ascendis Pharma UK
26-Mar-2025 Secarna Pharmaceuticals to present positive new data on antisense oligonucleotide SECN-15 targeting NRP1 as monotherapy and in combination with immune checkpoint inhibitors at AACR Secarna Pharmaceuticals GmbH & Co. KG
26-Mar-2025 New Publication Reveals the Impact of Socioeconomic Factors on Health Outcomes and Importance of Self-Care Bayer
26-Mar-2025 New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings AstraZeneca